01
Context / Background
Translational research converts laboratory discoveries into technologies and products. In India, academic institutions often provide lab facilities, but the journey from a lab-scale experiment (e.g., 10-500 grams of a chemical) to full production is long and under-supported. The article highlights that most ideas stall in the middle, where both cost and risk are high, before investors are willing to enter.
02
The 'Valley of Death' and TRL
Technology Readiness Levels (TRL) map technology maturity: lab work is TRL 1-3, piloting is TRL 4-7, and commercial deployment is TRL 8-10. The 'Valley of Death' lies in TRL 4-7, where prototyping and piloting require significant investment but success is not assured. Academia typically offers IP at TRL 3, while industry wants ready-to-buy technology at TRL 8.
03
ITRI's Model and Focus Areas
ITRI is a non-profit, philanthropic initiative founded by Mirik Gogri. Instead of solving one disease or product, it aims to create a platform-level translational research infrastructure. It will set up 10-12 hubs in 7-8 academic institutions, augmenting equipment and talent. Focus themes include healthcare and biologics, energy and climate, and advanced manufacturing, with areas like membranes, spatial transcriptomics, 2D materials, continuous chemical manufacturing, plant phenotyping, solar reliability, and modular diagnostics.
04
Funding and Challenges
ITRI and other philanthropists have committed over ₹150 crore for the initial hubs. Gogri estimates India needs 50-60 translational research centres at a five-year cost of ₹7,000-10,000 crore; a semiconductor fabrication facility may cost ₹500 crore, while ceramics may cost ₹25 crore. Challenges include running piloting facilities that are larger than academic labs, and getting Indian philanthropy to co-fund.
05
Ecosystem, Policy Linkage, and Way Forward
India's overall R&D spending is low, and government does a significant part; the private sector needs to raise its spend. The ₹1 lakh crore India's Research, Development, and Innovation Fund is a positive development for startups, and MeitY spends on areas like 2D materials fabrication. The Economic Survey mentions translational research, and ANRF has launched the Anusandhan Translational Research and Innovation Initiative. Globally, Germany's Fraunhofer institutes, China's state-driven model, and the US ARPA approach demonstrate different translation models. ITRI also wants to become an advocacy group, sharing playbooks and helping government and institutions scale the effort.